Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE American:NBY)

4.58
Delayed Data
As of Nov 20
 -0.025 / -0.54%
Today’s Change
2.25
Today|||52-Week Range
5.00
+38.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues4.1M3.7M4.1M4.1M
 
 
 
 
 
Cost of Goods Sold792.0K570.0K680.0K503.0K
 
 
 
 
 
Depreciation And Amortization16.0K18.0K18.0K18.0K
 
 
 
 
 
 
Operating ExpensesGross Income3.3M3.1M3.4M3.6M
 
 
 
 
 
General Expenses5.3M6.9M5.2M5.7M
 
 
 
 
 
Research And Development156.0K62.0K70.0K132.0K
 
 
 
 
 
Total Operating Expenses6.1M7.5M5.9M6.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.0M-3.8M-1.8M-2.2M
 
 
 
 
 
Extraordinary Credit381.0K--15.0K0.00
 
 
 
Extraordinary Charge---235.0K---281.0K
 
 
 
Other Expenses1.0K2.0K4.0K3.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-4.0M-1.7M-2.4M
 
 
 
 
 
Income Taxes0.00-1.0K0.000.00
 
 
Net Income-1.6M-4.0M-1.7M-2.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.1M15.3M15.3M15.3M
 
 
 
 
 
Shares To Calculate EPS Diluted15.5M15.3M15.3M15.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.13-$0.26-$0.11-$0.16
 
 
 
 
 
EPS Diluted-$0.11-$0.26-$0.11-$0.16